• $1.6B
    Market Cap
  • 230.96%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
46.0M
+4,174.51%
1.1M
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
Gross Profit
46.0M
+4,174.51%
1.1M
N/A
Sales and Marketing Expense
300,000
0.00%
300,000
N/A
Research and Development Expense
-97.6M
+49.35%
-65.3M
N/A
Depreciation and Amortization Expense
1.6M
+14.49%
1.4M
N/A
Total Operating Expenses
114.2M
+39.50%
81.9M
N/A
Operating Profit
-68.3M
-15.50%
-80.8M
N/A
Interest Income
19.5M
+126.65%
8.6M
N/A
Interest Expense
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
19.5M
+126.65%
8.6M
N/A
Total Nonoperating Income and Expense
19.4M
+127.86%
8.5M
N/A
Income before Taxes
-48.9M
-32.41%
-72.3M
N/A
Income Taxes
12,000
+102.41%
-498,000
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-48.9M
-31.92%
-71.8M
N/A
Net Income from Continuing Operations Applicable to Common
-48.9M
-31.94%
-71.8M
N/A
Basic EPS and Net Income
-1.10
-84.85%
-7.26
N/A
Diluted EPS and Net Income
-1.10
-84.85%
-7.26
N/A
Basic Weighted Average Shares
44.3M
+347.46%
9.9M
N/A
Diluted Weighted Average Shares
44.3M
+347.46%
9.9M
N/A
Balance Sheet
Cash and Cash Equivalents
120.7M
-49.32%
238.2M
N/A
Short-Term Investments
270.4M
+139.84%
112.7M
N/A
Cash and Cash Equivalents and Short-Term Investments
391.1M
+11.45%
350.9M
N/A
Total Current Assets
411.0M
+15.17%
356.8M
N/A
Accumulated Depreciation
4.4M
+48.58%
2.9M
N/A
Property and Plant and Equipment and Net
4.4M
-12.89%
5.1M
N/A
Total Long-Term Assets
816,000
+205.62%
267,000
N/A
Total Assets
596.2M
+30.58%
456.6M
N/A
Income Taxes Payable
N/A
N/A
0
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
Total Current Liabilities
86.9M
+576.56%
12.8M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
0
-100.00%
33,000
N/A
Total Liabilities
214.3M
+486.90%
36.5M
N/A
Retained Earnings
-167.3M
+41.29%
-118.4M
N/A
Total Stockholders Equity
381.9M
-9.08%
420.0M
N/A
Total Shares Outstanding
44.8M
+0.86%
44.4M
N/A
Cash Flow
Cash from Operating Activities
110.2M
+263.32%
-67.5M
N/A
Capital Expenditures
518,000
-75.37%
2.1M
N/A
Cash from Investing Activities
-229.4M
+42.81%
-160.6M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
1.7M
-99.55%
377.8M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
-148.63%
N/A
N/A
N/A
Return on Assets
-9.29%
N/A
N/A
N/A
Return on Equity
-12.19%
N/A
N/A
N/A
Revenue Growth
4,174.51%
N/A
N/A
N/A
Current Ratio
4.73
N/A
N/A
N/A
Cash Ratio
1.39
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow